Evelo Biosciences | EFFECT: Others
Evelo Biosciences | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Evelo Biosciences | 8-K: Current report
Evelo Biosciences | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Evelo Biosciences | S-8 POS: S-8 POS
Evelo Biosciences | S-8 POS: S-8 POS
Evelo Biosciences | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Evelo Biosciences | DEFA14A: Others
Evelo Biosciences | DEF 14A: Definitive information statements
Evelo Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(0.000%),Abigail P. Johnson(0.000%)
Evelo Biosciences | 8-K: Current report
Evelo Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Evelo Biosciences | 8-K: Current report
Evelo Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(7.041%),Abigail P. Johnson(7.041%)
Evelo Biosciences | 10-Q: Q3 2023 Earnings Report
Evelo Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Bodmer Mark
Evelo Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer McHale Duncan
Evelo Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer GILL SIMBA
Evelo Biosciences | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Thorell Marella
Evelo Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Bodmer Mark